Trials / Withdrawn
WithdrawnNCT02309203
Canadian Study of the MicroVention Flow Re-Direction (FRED) Endoluminal Device Stent System in the Treatment of Intracranial Aneurysms
Canadian Study of the MicroVention Flow Re-Direction (FRED) Endoluminal Device Stent System in the Treatment of Intracranial Aneurysms - The CanFRED Trial
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM) · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study objective is to evaluate the safety and effectiveness of the MicroVention FRED System when used in the treatment of wide-necked intracranial aneurysms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FRED | Flow Re-Direction Endoluminal Device |
Timeline
- Primary completion
- 2017-02-01
- Completion
- 2017-09-01
- First posted
- 2014-12-05
- Last updated
- 2015-07-28
Source: ClinicalTrials.gov record NCT02309203. Inclusion in this directory is not an endorsement.